In order to enable an iCal export link, your account needs to have an API key created. This key enables other applications to access data from within Indico even when you are neither using nor logged into the Indico system yourself with the link provided. Once created, you can manage your key at any time by going to 'My Profile' and looking under the tab entitled 'HTTP API'. Further information about HTTP API keys can be found in the Indico documentation.
Additionally to having an API key associated with your account, exporting private event information requires the usage of a persistent signature. This enables API URLs which do not expire after a few minutes so while the setting is active, anyone in possession of the link provided can access the information. Due to this, it is extremely important that you keep these links private and for your use only. If you think someone else may have acquired access to a link using this key in the future, you must immediately create a new key pair on the 'My Profile' page under the 'HTTP API' and update the iCalendar links afterwards.
Permanent link for public information only:
Permanent link for all public and protected information:
Ion beam therapy: state-of-the-art and research opportunities
MPI Meeting rooms
MPI Meeting rooms
The energy deposition of swift ions in matter can be concentrated at a well-localized depth at the end of range, so-called Bragg peak, thus providing favorable physical and biological properties for cancer treatment. Compared to conventional external beam radiotherapy modalities, ion beams promise superior tumour-dose conformality and optimal sparing of surrounding critical organs and healthy tissue, with expected benefits for deep-seated, inoperable tumour sites as well as pediatric patients. Hence, interest in this emerging technology has rapidly increased worldwide in the last decade(s), with about 70 ion (mostly proton) therapy facilities currently in operation and about the same amount in construction or planning.
Despite constant technological advances, full clinical exploitation of the favorable ballistic properties of ion beams in clinical practice is still hampered by the yet unsolved problem of range uncertainties, preventing the desired (sub)-millimeter localization of the Bragg peak (hence dose maximum) in tissue. Hence, several new approaches are being extensively investigated to tackle this issue at the stage of treatment planning and delivery. This presentation will thus review main ongoing developments and initial experience aiming to eventually harness the ballistic selectivity of ion beam therapy in pre-clinical and clinical applications.